Yardbarker
x
Tigers lefty Tarik Skubal discusses surgery rehab
Detroit Tigers starting pitcher Tarik Skubal Brad Rempel-USA TODAY Sports

Left-hander Tarik Skubal had a nice breakout season in 2021, tossing 149 1/3 innings that year with a 4.34 ERA. He seemed to take a step forward in 2022, getting his ERA down to 3.52 through 21 starts. Unfortunately, he required flexor tendon surgery in August, wiping out the rest of that season and likely some portion of his 2023 as well. With spring training just around the corner, Skubal has begun throwing from flat ground and discussed his rehab progress with Chris McCosky of the Detroit News.

“Everything has gone really well,” Skubal said. “The arm is responding well. I can’t complain about anything. I like where I’m at.” 

Though he seems encouraged by the progress, it seems he doesn’t want to set a specific target for his return. 

“I hate to put a date on it,” he said. “I’m going to be focusing on my day-to-day progress. I’m not going to set a date and then, if I’m not back by that date, be discouraged.” 

If someone were to say he won’t return at all this year? 

“I’d call them a liar.”

The fact that Skubal is feeling good is surely encouraging, but the return from flexor tendon surgery can be tricky. Danny Duffy underwent the procedure in October 2021 and was signed by the Dodgers with the hope of returning at some point the following season. However, a setback during his recovery eventually caused him to miss the entire campaign. Matthew Boyd had the same surgery in September 2021 and returned to the mound just shy of a year later.

Boyd signed with the Tigers this offseason and is now Skubal’s teammate. 

“It’s a long process and it’s not linear,” Boyd said of his experience. “That was my first time being on the IL like that, my first time having that experience. The rehab process has its ups and downs, and that was unique. It takes patience, and that produces perseverance, right? And that is staying strong.”

For his part, Skubal seems to acknowledge that he has to keep a level head and can’t start ramping up too quickly. 

“Yeah, that’s been my problem for the last six months,” Skubal said. “Even before the surgery, that was my problem. But, these guys do a good job. I think I am progressing, and that is what I’m chasing — progress. If I can just get a little better each day and keep progressing, that’s going to put me back on the field at the right time.”

The Tigers rotation seems to be in wait-and-see mode for 2023, since there are question marks around so many of their long-term pieces. Casey Mize had Tommy John surgery in June of last year and will miss most or perhaps all of 2023. Spencer Turnbull will be back in action this year but missed all of 2022 due to his own Tommy John procedure. Matt Manning only made 12 starts last year due to shoulder inflammation and then finished the year on the injured list due to a forearm strain, though he was reported as healthy back in November. Eduardo Rodriguez signed a five-year deal with the Tigers, but the first season saw him miss time both due to injury and personal issues, making just 17 starts. He’ll look to get back on track in 2023 but can opt out of the remainder of his deal after the season.

With all of that uncertainty, the club signed Boyd and Michael Lorenzen to one-year deals. They figure to be in the Opening Day rotation next to Manning, Rodriguez and Turnbull, with other options on the 40-man such as Joey Wentz and Beau Brieske. If the club is out of contention this summer, Boyd and Lorenzen could be trade chips if they are pitching well, since they will be impending free agents. Whenever Skubal is healthy and back on track, he’ll jump into that mix. He’s on pace to qualify for arbitration after the upcoming season and reach free agency after the 2026 campaign.

This article first appeared on MLB Trade Rumors and was syndicated with permission.

More must-reads:

Customize Your Newsletter

+

Get the latest news and rumors, customized to your favorite sports and teams. Emailed daily. Always free!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.